282 related articles for article (PubMed ID: 31816901)
1. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.
Abdelaziz Mohamed I; Gadeau AP; Hasan A; Abdulrahman N; Mraiche F
Cells; 2019 Dec; 8(12):. PubMed ID: 31816901
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders.
Vianello E; Kalousová M; Dozio E; Tacchini L; Zima T; Corsi Romanelli MM
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759639
[TBL] [Abstract][Full Text] [Related]
3. Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production.
Sawaki D; Czibik G; Pini M; Ternacle J; Suffee N; Mercedes R; Marcelin G; Surenaud M; Marcos E; Gual P; Clément K; Hue S; Adnot S; Hatem SN; Tsuchimochi I; Yoshimitsu T; Hénégar C; Derumeaux G
Circulation; 2018 Aug; 138(8):809-822. PubMed ID: 29500246
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin Is an Integral Mediator of Cardiac Interstitial Fibrosis in Models of Human Immunodeficiency Virus Infection.
Robinson JA; Mahmud FJ; Greif E; Toribio M; Zanni MV; Brown AM; Burdo TH
J Infect Dis; 2023 Jul; 228(2):122-132. PubMed ID: 37162508
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.
Vetrone SA; Montecino-Rodriguez E; Kudryashova E; Kramerova I; Hoffman EP; Liu SD; Miceli MC; Spencer MJ
J Clin Invest; 2009 Jun; 119(6):1583-94. PubMed ID: 19451692
[TBL] [Abstract][Full Text] [Related]
6. The critical role of osteopontin (OPN) in fibrotic diseases.
Tang Z; Xia Z; Wang X; Liu Y
Cytokine Growth Factor Rev; 2023 Dec; 74():86-99. PubMed ID: 37648616
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin and cardiovascular system.
Okamoto H
Mol Cell Biochem; 2007 Jun; 300(1-2):1-7. PubMed ID: 17136480
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Osteopontin Enhances β₂-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes.
Pollard CM; Desimine VL; Wertz SL; Perez A; Parker BM; Maning J; McCrink KA; Shehadeh LA; Lymperopoulos A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897705
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin expression is required for myofibroblast differentiation.
Lenga Y; Koh A; Perera AS; McCulloch CA; Sodek J; Zohar R
Circ Res; 2008 Feb; 102(3):319-27. PubMed ID: 18079410
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
11. IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.
Yu Q; Vazquez R; Khojeini EV; Patel C; Venkataramani R; Larson DF
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H76-85. PubMed ID: 19429811
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López B; González A; Lindner D; Westermann D; Ravassa S; Beaumont J; Gallego I; Zudaire A; Brugnolaro C; Querejeta R; Larman M; Tschöpe C; Díez J
Cardiovasc Res; 2013 Jul; 99(1):111-20. PubMed ID: 23619422
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cyclic AMP Signaling in Cardiac Fibrosis.
Delaunay M; Osman H; Kaiser S; Diviani D
Cells; 2019 Dec; 9(1):. PubMed ID: 31888098
[TBL] [Abstract][Full Text] [Related]
14. Role of Osteopontin in Liver Diseases.
Wen Y; Jeong S; Xia Q; Kong X
Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
16. SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis.
Uchinaka A; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N; Yamamoto H; Kawaguchi N
Mol Cell Biochem; 2015 Oct; 408(1-2):191-203. PubMed ID: 26112906
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin in Cardiovascular Diseases.
Shirakawa K; Sano M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356671
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.
Jia Q; Ouyang Y; Yang Y; Yao S; Chen X; Hu Z
Lung; 2024 Feb; 202(1):25-39. PubMed ID: 38060060
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring.
Mori R; Shaw TJ; Martin P
J Exp Med; 2008 Jan; 205(1):43-51. PubMed ID: 18180311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
